首页>
外国专利>
Vaccine therapy for choroidal neovascularization
Vaccine therapy for choroidal neovascularization
展开▼
机译:脉络膜新生血管的疫苗治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present inventors administered a peptide derived from VEGFR-2, which is known as one of the proteins involved in neovascularization, to model mice (A2/Kb transgenic mice) expressing human HLA-A*0201, and tested whether or not the peptide has vaccine effect. As a result, the present inventors successfully discovered that vaccination using this peptide as an antigen is effective for inhibition of choroid neovascularization, and thereby completed the present invention. More specifically, the present invention provides vaccines for treatment and/or prevention of diseases caused by choroid neovascularization (neovascular maculopathy), which contain a VEGFR-2-derived peptide as an active ingredient.
展开▼